Finance : Aimmune's 'First-Of-Its-Kind' Peanut Allergy Drug Receives FDA Approval

Aimmune's 'First-Of-Its-Kind' Peanut Allergy Drug Receives FDA ApprovalThe FDA approved Palforzia allergen powder for treating patients with confirmed diagnosis of peanut allergy, the Brisbane, California-based company said in a late Friday release. An FDA panel, which reviewed the BLA for Palforzia back in September, voted 7-2, recommending the approval on the grounds of efficacy and safety. Palforzia is an oral immunotherapy meant to mitigate allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut.




https://ift.tt/eA8V8J from Yahoo Finance https://ift.tt/2Uf6aQu
February 02, 2020 at 02:23AM

Comments